Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model

Frank Griscelli, Hong Li, Chiat Cheong, Paule Opolon, Annelise Bennaceur-Griscelli, Gilles Vassal, Jeannette Soria, Claudine Soria, He Lu, Michel Perricaudet, Patrice Yeh

    Research output: Contribution to journalArticlepeer-review

    115 Citations (Scopus)

    Abstract

    The objective of the present study was to evaluate the antitumor effect of a defective adenovirus expressing a secretable angiostatin-like molecule (AdK3) in combination with radiotherapy in rat C6 gliomas s.c. preestablished into athymic mice. In vitro, the combination regimen was significantly (P < 0.001) more cytotoxic for human microcapillary endothelial cells than either treatment alone, whereas survival of C6 glioma cells was not affected in the conditions used. Radiotherapy and AdK3 gene delivery was then studied on well established C6 xenografts (165 ± 70 mm3). In these tumors, AdK3 intratumoral injections had only a marginal effect. Interestingly, when experimental radiotherapy was added, significantly higher (P < 0.005), and possibly synergistic, antitumoral effects were observed that tightly correlated a marked decrease of intratumoral vascularization. The combination of radiotherapy and AdK3 intratumoral injections also revealed a significant (P < 0.05) inhibition of tumor growth as compared with either treatment alone for larger tumors (467 ± 120 mm3). Altogether, these data emphasize the potential of combining a destructive strategy directed against the tumor cells with an anti-angiogenic approach to fight cancer.

    Original languageEnglish
    Pages (from-to)6698-6703
    Number of pages6
    JournalProceedings of the National Academy of Sciences of the United States of America
    Volume97
    Issue number12
    DOIs
    Publication statusPublished - 6 Jun 2000

    Keywords

    • Angiogenesis
    • Cancer
    • Recombinant adenovirus

    Cite this